Conclusions The major hindrance in achieving a good cure-rate was a high death rate and default. Early diagnosis of MDR-TB and adequate clinical monitoring during treatment is essential. Identifying adverse drug reactions, other co morbidities and their optimal management is the key to success. (Source: Egyptian Journal of Chest Diseases and Tuberculosis)